Cytokines in chronic lung disease of prematurity

被引:76
|
作者
Kotecha, S
机构
关键词
inflammation; fibrosis; cytokines; chronic lung disease of prematurity;
D O I
10.1007/BF01958074
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Chronic lung disease of prematurity (CLD) is a common respiratory disorder of preterm infants. At autopsy, fibroblast proliferation, and components of the extracellular matrix, including collagen and fibronectin, are markedly increased in the lungs of infants who die from CLD. Examination of broncho-alveolar fluid suggests that the persistence of neutrophils is associated with the development of CLD. In our studies, the pro-inflammatory cytokines, interleukin-1 beta (IL-1 beta) and interleukin-6, (n-6) and mediators which reflect neutrophil recruitment and activation, including soluble intercellular adhesion molecule, interleukin-8 (IL-8) and neutrophil elastase, were increased in lavage fluid obtained from infants who developed CLD when compared to infants who did not. Furthermore, semiquantitative reverse transcroptase-polymerose chain reaction of mRNA extracted from lavage cells suggested that luminal cells may be the source of IL-6 detected in lavage fluid but non-luminal cells may be the sources of IL-1 beta and IL-8. Fibrosis is thought to be mediated by the pro-fibrotic cytokines including transforming growth factor-beta(1) (TGF-beta(1)). Both active and total TGF-beta 1 were increased in lavage fluid from infants who developed CLD. Furthermore, both type I procollagen and TGF-beta were increased qualitatively in lung tissue obtained at autopsy from infants who died from respiratory failure. The increase in inflammatory mediators was maximal at 10 days of age. By contrast, the increase in TGF-beta, was maximal at 4 days of age. This suggests that the interaction between inflammation and fibrosis in CLD is complex, and that prenatal factors may be important in the pathogenesis of CLD.
引用
收藏
页码:S14 / S17
页数:4
相关论文
共 50 条
  • [1] Downregulatory cytokines in tracheobronchial aspirate fluid from infants with chronic lung disease of prematurity
    Jónsson, B
    Li, YH
    Noack, G
    Brauner, A
    Tullus, K
    ACTA PAEDIATRICA, 2000, 89 (11) : 1375 - 1380
  • [2] CHRONIC LUNG-DISEASE OF PREMATURITY
    SCHICK, JB
    GOETZMAN, BW
    PEDIATRICS, 1985, 76 (04) : 652 - 652
  • [3] Diuretics and Chronic Lung Disease of Prematurity
    Luc P Brion
    Sin Chuen Yong
    Iris A Perez
    Robert Primhak
    Journal of Perinatology, 2001, 21 (5) : 269 - 271
  • [4] Lung development is impaired in chronic lung disease of prematurity
    Albertine, KH
    Pierce, RA
    Starcher, BC
    MacRitchie, AN
    Carlton, DP
    Bland, RD
    FASEB JOURNAL, 1999, 13 (05): : A1154 - A1154
  • [5] Airway Metabolome and Chronic Lung Disease of Prematurity
    Rastogi, Deepa
    Aschner, Judy L.
    JOURNAL OF PEDIATRICS, 2015, 166 (02): : 224 - 226
  • [6] Chronic lung disease of prematurity: A short history
    Philip, Alistair G. S.
    SEMINARS IN FETAL & NEONATAL MEDICINE, 2009, 14 (06): : 333 - 338
  • [7] Chronic lung disease of prematurity and bronchopulmonary dysplasia
    de Souza, Gabriela de Azevedo Bastian
    Hanel, Maria Paula
    Herter, Eduardo da Costa
    Pinto, Leonardo Araujo
    Jones, Marcus Herbert
    JORNAL BRASILEIRO DE PNEUMOLOGIA, 2024, 50 (04)
  • [8] Mast Cells In Chronic Lung Disease Of Prematurity
    Silver, R.
    Veerappan, A.
    Chan, W.
    Sung, B.
    O'Connor, N. A.
    Brazin, J. A.
    Silverman, M. L.
    Summers, B.
    Benedict, P.
    Thompson, M.
    Worgall, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [9] Chronic lung disease in infancy following prematurity
    Gaillard, EA
    Shaw, BN
    HOSPITAL MEDICINE, 2003, 64 (11): : 640 - 643
  • [10] Medication Adherence in Chronic Lung Disease of Prematurity
    Collaco, J. M.
    Kole, A.
    Okelo, S.
    Riekert, K. A.
    Eakin, M.
    McGrath-Morrow, S. A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181